IRLAB Therapeutics is a drug discovery and development company providing novel treatments for disorders of the brain.
IRLAB Therapeutics has raised $11.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in May 2026.
IRLAB Therapeutics's investors include Michael J. Fox Foundation, New Leaf Venture Partners, EISMEA, Fenja Capital, Marinvest Holding.
IRLAB Therapeutics is headquartered in Göteborg, Sweden.
IRLAB Therapeutics is a drug discovery and development company providing novel treatments for disorders of the brain.
IRLAB Therapeutics is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"IRLAB Therapeutics — Funding & Investors." VCBacked, May 5, 2026, https://www.vcbacked.co/company/irlab-therapeutics. Accessed September 30, 2026.
VCBacked. (2026). IRLAB Therapeutics — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/irlab-therapeutics
{{cite web |title=IRLAB Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/irlab-therapeutics |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated